Skip to content

InsiderTradesSIGMA

RecommendationsTOP Fundamental picks TerminalNEW

Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FR US DE CH GB CA IT ES NL BE NO FI DK AU AT IE KR IN JP HK+ 8 markets

Recommendations
Fundamental picks
Terminal
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Archive

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

Built bySimon Azoulay

All systems operational

Companies · Healthcare & Pharma · InsiderTrades Sigma · page 31

Sector3,940

Healthcare & Pharma

Lixte Biotechnology Holdings, INC.

LogicMark, Inc.

Longeveron Inc.

Longeveron Inc.

Lotus Eye Hospital and Institute Limited

Lucid Diagnostics Inc.

Lucira Health, Inc.

Lumito AB (publ)

Lumito AB (publ)

Lumito AB (publikt)

Lumito AB (publikt)

Lumos Diagnostics Holdings Limited

Lumos Pharma, INC.

Lyell Immunopharma, Inc.

Lyka Labs Limited

Lyra Therapeutics, Inc.

Lytix Biopharma ASA

MAIA Biotechnology, Inc.

MAPS MAPS GROUP: IN THE FIRST HALF, STRONG GROWTH IN PRODUCTS DRIVEN BY THE HEALTHCARE SECTOR. CUSTOM PROJECTS RECORD A DECLINE

MAPS MAPS GROUP: THE TRANSITION TOWARDS PROPRIETARY SOFTWARE PRODUCTS CONTINUED IN 2025, DRIVEN BY HEALTHCARE

MAPS MAPS GROUP: THE TRANSITION TOWARDS PROPRIETARY SOFTWARE PRODUCTS CONTINUED IN 2025, DRIVEN BY HEALTHCARE

MARIA ISABEL LOZANO FERNANDEZ

MASI AGRICOLA MASI AGRICOLA - C.S. ASSEMBLEA STRAORDINARIA DEL 04.03.2024

MBK Wellness Holdings株式会社

MEI Pharma, Inc.

MERCK Kommanditgesellschaft auf Aktien

MOLOGEN Lifescience AG

MPH Health Care AG

MPM Corpóreos S.A.

MSP Recovery, Inc.

Mabwell (Shanghai) Bioscience Co., Ltd. - B

Macrogenics INC

Madrigal Pharmaceuticals, INC.

Magellan Health INC

← PreviousPage 31 of 79Next →